Smart Medicines Lead Week’s Health Innovation Funding | StartUp Health Insights: Week of Mar 25, 2025
Investments in programmed medicines, AI-powered pathology, digital pharmacies, senior care solutions, and stroke imaging highlight a week of strong health tech funding—from Boston to Mumbai, Oxford to Tel Aviv.
Written by Nicole Kinsey
Ampersand Biosciences, a Boston, MA-based multi-product platform company developing smart medicines, raised $65M from Ampersand’s founder, Flagship Pioneering, Eli Lilly & Company, and other investors. <source>
Navina, a New York, NY-based AI-powered clinical intelligence platform, raised $55M led by Growth Equity at Goldman Sachs Alternatives, with participation from Vertex Ventures Israel, Grove Ventures, and ALIVE. <source>
Proscia, a Philadelphia, PA-based software company transitioning pathology to digital and AI, raised $50M led by Insight Partners. <source>
Truemeds, a Mumbai, India-based digital pharmacy and telehealth platform, raised Rs 375 crore ($44M) led by Accel India, with participation from WestBridge and Info Edge. <source>
Inspiren, an AI-focused solutions provider for senior living, raised $35M led by Avenir, with participation from Primary Venture Partners, Story Ventures, Third Prime, and Studio VC. <source>
Sibel Health, a Chicago, IL-based patient monitoring company spin-out of Northwestern University, raised $30M led by Steele Foundation for Hope, with participation by Dräger. <source>
Brainomix, an Oxford, UK-based company providing AI-powered imaging tools in stroke and lung fibrosis, raised £14M ($18M) co-led by Parkwalk Advisors and the Boehringer Ingelheim Venture Fund (BIVF), with participation from Hostplus. <source>
Jutro Medical, a Warsaw, Poland-based AI-first primary care provider integrating online and offline care, raised €12M ($13M) led by KAYA VC and RIO ASI, with participation from Inovo VC and a debt component provided by mBank. <source>
brain.space, a Tel Aviv, Israel-based creator of a Brain-Data-as-a-Service Ecosystem for exclusive generative AI mental modeling, raised $11M led by Toyota Ventures, with participation from Mangrove Capital Partners, The Group Ventures, and a $3.5M grant by the Israel Innovation Authority. <source>
TadHealth, a Newport Beach, CA-based mental healthcare administration platform for schools, raised $7.9M from undisclosed investors. <source>
Madison Scientific, a Chicago, IL-based medical device company developing smart electro-mechanical solutions for patients with neurologic conditions, raised $7M co-led by WARF Ventures, the Isthmus Project, and a medical device entrepreneur/investor, with participation from other institutional investors, family offices, and angel investors. <source>
Biophy, a Philadelphia, PA-based developer of AI solutions to accelerate pharmaceutical research and development, raised $6.6M from undisclosed investors. <source>
Kyberlife, a Singapore-based healthcare B2B e-commerce platform, raised $3M led by 5I Ventures, with participation from East Ventures, A2D Ventures, and NUS Alumni Ventures. <source>
Coreline Soft, a Seoul, South Korea-based developer of AI-based imaging diagnostics products, raised 3.4B won ($2.3M) from Vuno. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Innovation
Are You Ready to Find Your Tribe?
We’re looking for founders and CEOs leading digital health, life science, or biotech companies that are solving the biggest health challenges of our time – and want to build a better network to change the world. Our communities include: Alzheimer’s Disease, Cardiometabolic Health, Food as Medicine, Mental & Behavorial Health, Type 1 Diabetes, and more.
If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.
Follow us on social media for daily updates on Health Transformers: LinkedIn, Facebook, and Instagram.
